Liquid Biopsy Cell-Free BRAF Test
Revolutionary Non-Invasive Cancer Detection
The Liquid Biopsy Cell-Free BRAF Test represents a groundbreaking advancement in cancer diagnostics, offering a sophisticated approach to detecting specific genetic mutations associated with various malignancies. This innovative test analyzes circulating tumor DNA (ctDNA) from peripheral blood samples, providing crucial genetic information without the need for invasive tissue biopsies. The BRAF gene plays a critical role in cell growth and division, and specific mutations in this gene can drive cancer development and progression.
What Does the Test Measure?
This advanced diagnostic test specifically detects:
- BRAF V600E mutations and other BRAF variants
- Circulating tumor DNA fragments in blood plasma
- Genetic alterations that influence treatment response
- Mutation burden for therapeutic monitoring
Who Should Consider This Test?
The Liquid Biopsy Cell-Free BRAF Test is recommended for:
- Patients with suspected melanoma, colorectal cancer, or thyroid cancer
- Individuals experiencing unexplained symptoms that may indicate cancer
- Patients undergoing cancer treatment who require monitoring
- Those with family history of BRAF-related cancers
- Individuals seeking non-invasive cancer screening options
- Patients requiring genetic profiling for targeted therapy selection
Key Benefits of Liquid Biopsy BRAF Testing
- Non-Invasive Procedure: Simple blood draw eliminates need for surgical biopsies
- Early Detection: Identifies genetic mutations before traditional methods
- Treatment Guidance: Helps determine appropriate targeted therapies
- Monitoring Capability: Tracks treatment response and disease progression
- Minimal Discomfort: Peripheral blood collection is quick and comfortable
- Rapid Results: 5-7 day turnaround time for prompt clinical decisions
Understanding Your Test Results
Your Liquid Biopsy Cell-Free BRAF Test results will provide valuable insights into your genetic profile:
- Positive Result: Indicates presence of BRAF mutations, suggesting potential for targeted therapy
- Negative Result: No detectable BRAF mutations found in the sample
- Quantitative Data: Provides mutation burden information for treatment monitoring
- Clinical Interpretation: Results are accompanied by expert analysis and recommendations
All results should be discussed with your healthcare provider for proper interpretation and treatment planning.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | Liquid Biopsy Cell-Free BRAF Test |
| Discount Price | $450 USD |
| Regular Price | $600 USD |
| Turnaround Time | 5-7 Days |
| Sample Type | Peripheral Blood (Streck Tube) |
| Testing Method | Droplet Digital PCR |
Nationwide Testing Availability
We have testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our nationwide network ensures accessible, high-quality genetic testing services for patients throughout the country.
Book Your Test Today
Take the first step toward personalized cancer care with our advanced Liquid Biopsy Cell-Free BRAF Test. Our experienced team is ready to assist you with scheduling and answer any questions you may have about the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or learn more about this revolutionary cancer detection method.
Note: This test requires a doctor’s prescription for most cases. Prescription requirements do not apply to surgery and pregnancy cases or individuals planning international travel.
